Table 2.
Characteristics of propensity-matched patients
| Item | Home care group (n = 69) | Hospital care group (n = 69) | P | Standardized difference |
|---|---|---|---|---|
| Gender (n, male/female) | 35/34 | 36/33 | 0.87 | 0.03 |
| Age (yr, mean ± SD) | 70.7 ± 13.9 | 70.7 ± 10.8 | 0.99 | 0.002 |
| Primary site (n) | 1.00 | |||
| Lung | 11 | 13 | 0.08 | |
| Stomach/esophagus | 22 | 23 | 0.03 | |
| Liver/biliary tract/pancreas | 17 | 15 | 0.07 | |
| Large intestine | 9 | 8 | 0.04 | |
| Breast | 2 | 2 | 0 | |
| Others | 8 | 8 | 0 | |
| Performance status (n) | 0.99 | |||
| 0 | 0 | 0 | (incalculable) | |
| 1 | 12 | 12 | 0 | |
| 2 | 22 | 20 | 0.06 | |
| 3 | 27 | 28 | 0.03 | |
| 4 | 8 | 9 | 0.04 | |
| Use anti-cancer agents (n, used/unused)a | 1/68 | 2/67 | 1.00 | 0.10 |
aThis is about whether patients used anti-cancer agents or not from 1 month before referral to Palliative Care Team to death.